N
NVision Imaging Technologies
A developer of quantum MRI agents and polarization devices for assessing early patient response to treatment at the metabolic level
About NVision Imaging Technologies
NVision Imaging Technologies leverages cutting-edge quantum physics to revolutionize medical imaging. The company specializes in enhancing existing MRI systems to provide detailed metabolic insights at the cellular level, enabling early diagnosis and precise treatment monitoring for conditions such as ischemic heart disease, heart failure, cancer, and chronic kidney failure. By utilizing hyperpolarization technology, NVision's platform allows for rapid and accurate measurement of natural metabolites, offering critical information on tumor activity and viability in less than 30 seconds. This technology is particularly valuable for differentiating between resistant and sensitive tumors, allowing for timely adjustments in therapy. NVision serves both preclinical and clinical research markets, as well as clinical applications, providing robust, fast, and user-friendly solutions. The business model focuses on selling and licensing its advanced imaging technology to healthcare providers, research institutions, and pharmaceutical companies. Revenue is generated through the sale of equipment, software licenses, and ongoing service agreements.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2015
- Headquarters
- Ulm, Germany
- Employees
- 126
- Open positions
- 5
- Dealroom signal
- 92.3/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Biotechnology, Oncology, Medical Imaging, Spinout, Clinical Decision Support
- Technology
- Hardware, Deep Tech, Nanotech, Quantum Technologies
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VCOther financing | Mar 2025 | $0 | — | Entrée Capital · Playground Global · b2venture · Glocap | — |
| SERIES AOther financing | Jun 2023 | $30M | $120M | Lauder Partners · Pathena · b2venture · Sparkassenkapital Ulm | ↗ |
Growth signals
Latest recorded traffic for NVision Imaging Technologies is 520 monthly website visits, down 93.1% over the last three months. NVision Imaging Technologies's team grew 10.5% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed5 investors entered at this stage
European Commission
Playground Global
b2venture
Invest.BW
German Federal Ministry of Research, Technology and Space
Series A8 investors entered at this stage
Lauder Partners
Pathena- SUSparkassenkapital Ulm
Entrée Capital
ES Kapital
Glocap
Abbott
Sparkasse Ulm
Other known investors1 additional known investor
University of Ulm
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about NVision Imaging Technologies on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See NVision Imaging Technologies’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.